Inhaler prescribing errors: Identifying risks and improving patient safety
Home » Case studies » Inhaler prescribing errors: Identifying risks and improving patient safety
We improved patient safety and raised awareness across GPs, hospitals and community pharmacy of the risks of prescribing inhalers containing duplicate ingredients from the same drug group by identifying patients who were prescribed and using duplicate inhalers and highlighting the side effects this caused.
Our Procurement teams – healthcare and goods and services – have once again achieved the Chartered Institute of Procurement and Supply (CIPS) Corporate Ethics…
Delivering a wide range of support functions through transactional services, business partnering and transformation that drives efficiencies and releases value and time…
Supporting ICSs with approaches to design and deliver effective communication, engagement and behavioural insights as a key enabler for system change and…
Acting as an independent and trusted partner within the system to facilitate working across stakeholders and integrate elements of the provider system…
Digitising care and partnering with systems for the transformation of digitally enabled service delivery (and other supporting processes) across vision, planning and…
Supporting systems to build a sustainable and integrated workforce, transforming systems, organisations and the workforce experience to improve resilience.
Providing end-to-end funded care services, including patients as active partners in identifying their healthcare needs and then commissioning care to meet these.…
Applying intelligence-led understanding of the health of the population to support the redesign of care and improve patient and financial outcomes across…
Supporting providers to work together at a place and neighbourhood level to manage common resources, integrate community teams, improve health and reduce…